Log In
BCIQ
Print this Print this
 

ONO-6950

  Manage Alerts
Collapse Summary General Information
Company Ono Pharmaceutical Co. Ltd.
DescriptionLeukotrine receptor antagonist
Molecular Target Cysteinyl leukotriene receptor 2 (CYSLTR2) (CysLT2) ; Cysteinyl leukotriene receptor 1 (CysLT1)
Mechanism of ActionCysteinyl leukotriene receptor 1 (CysLT1) antagonist; Cysteinyl leukotriene receptor 2 (CysLT2) antagonist
Therapeutic Modality 
Latest Stage of DevelopmentPhase II
Standard IndicationAsthma
Indication DetailsTreat bronchial asthma
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today